Expect to See Xarelto Used in Children for Blood Clots

Xarelto (rivaroxaban) will be the first direct oral anticoagulant approved for venous thromboembolism (VTE) in CHILDREN.

VTE is a lot less common in kids than in adults...but it can occur in kids with certain risks, such as cancer or heart defects.

New evidence shows Xarelto is similarly effective to standard anticoagulants (heparin, warfarin) for treating VTE and preventing recurrence in children...without increasing bleeding risk.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote